Sight Sciences elects Burbach, Encrantz as directors; ratifies Deloitte as auditor

Sight Sciences, Inc.

Gerhard Burbach received 24,961,185 votes for and 2,877,580 withheld; Staffan Encrantz 23,901,624 for and 3,937,141 withheld.
Deloitte & Touche LLP ratified as independent auditor for FY 2026 with 41,059,471 for, 7,892 against, 388,895 abstain.
Annual meeting turnout was 41,456,258 shares (76.2% of outstanding) as of record date April 8, 2026.
No other stockholder proposals were presented or acted upon at the meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Sight Sciences, Inc. shareholders approved Election of two Class II directors to serve until 2029 at the 2026-06-04 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

Name of Director For Withheld Broker Non-Votes Gerhard Burbach 24,961,185 2,877,580 13,617,493 Staffan Encrantz 23,901,624 3,937,141 13,617,493

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Sight Sciences, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

For Against Abstain Broker Non-Votes 41,059,471 7,892 388,895 -

View on SEC.gov

1656 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Sight Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-259546

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.